statistiche ricercatore

Continente	#
EU - Europa	2.401
AS - Asia	516
NA - Nord America	464
SA - Sud America	70
Continente sconosciuto - Info sul continente non disponibili	33
AF - Africa	18
OC - Oceania	6
Totale	3.508

Nazione	#
SE - Svezia	1.860
US - Stati Uniti d'America	446
IT - Italia	334
SG - Singapore	159
CN - Cina	110
VN - Vietnam	65
BR - Brasile	46
HK - Hong Kong	44
RU - Federazione Russa	35
IN - India	32
FR - Francia	27
NL - Olanda	26
GB - Regno Unito	24
KR - Corea	20
BD - Bangladesh	16
DE - Germania	16
ES - Italia	16
JP - Giappone	12
CA - Canada	10
PL - Polonia	10
ID - Indonesia	9
PK - Pakistan	9
TR - Turchia	9
DK - Danimarca	8
FI - Finlandia	8
AR - Argentina	7
BE - Belgio	7
IE - Irlanda	7
PT - Portogallo	7
AU - Australia	6
ZA - Sudafrica	6
CL - Cile	5
EC - Ecuador	5
AT - Austria	4
PH - Filippine	4
SA - Arabia Saudita	4
UA - Ucraina	4
UZ - Uzbekistan	4
CO - Colombia	3
LB - Libano	3
MA - Marocco	3
MX - Messico	3
MY - Malesia	3
GA - Gabon	2
IL - Israele	2
IQ - Iraq	2
NP - Nepal	2
TN - Tunisia	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AZ - Azerbaigian	1
BB - Barbados	1
BY - Bielorussia	1
CH - Svizzera	1
CI - Costa d'Avorio	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GE - Georgia	1
GR - Grecia	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
LV - Lettonia	1
MK - Macedonia	1
MU - Mauritius	1
NG - Nigeria	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PY - Paraguay	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	3.475

Nome	#
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives	1.934
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases	289
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists	278
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists	269
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity	228
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases	137
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts	135
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants	74
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS	59
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants	58
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators	47
Totale	3.508

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2023/2024	34	0	0	5	2	2	4	7	0	7	2	0	5
2024/2025	326	2	17	46	14	21	19	12	20	34	54	30	57
2025/2026	3.068	101	57	58	97	124	60	110	66	152	2.040	61	142
2026/2027	80	80	0	0	0	0	0	0	0	0	0	0	0
Totale													3.508

Bicocca Open Archive